Taking into account the fact that LTC4 imposes changes in DCs that prevent their maturation we decided to evaluate their impact on the genesis of the selleck screening library adaptive response, through the analysis of the cytokines induced. With this aim, immature and activated DCs were cultured for 18 hr at 37° in presence or not of LTC4 (10–8 m). After incubation, culture supernatants were collected and we evaluated cytokines by ELISA. As shown in Fig. 3(a), LTC4 increased the production of TNF-α in immature DCs but was unable to reverse its release induced by LPS. Interestingly, LTC4 completely abolished the induction of IL-12p70 in LPS-stimulated DCs (Fig. 3b), indicating
an antagonistic effect of LPS. Therefore, LTC4 inhibits the induction of a Th1 profile by T CD4+ naive lymphocytes, by acting on activated DCs.34,35 Moreover, to further investigate the effect of LTC4 we decided to evaluate whether LTC4 could favour a tolerogenic state;36,37 however, when we analysed the release of IL-10 in culture supernatants, Pembrolizumab supplier we showed inhibition of this cytokine in LPS-treated DCs (Fig. 3c), whereas it was not modulated on immature DCs. Finally, as demonstrated in Fig. 3(d), LTC4 significantly stimulated the production of IL-12p40 by LPS-stimulated DCs. Taking into account that p40 is a chain shared by the cytokines IL-12 and IL-23 and the finding that IL-12p70 was strongly inhibited by LTC4, we decided to evaluate the presence of IL-23 in
supernatants of DCs. As shown in Fig. 4(e), LTC4 increased the release of IL-23 in LPS-stimulated DCs, a cytokine associated with the maintenance of Th17
profiles.38,39 The CysLTs exert their effects in several tissues through their action on CysLT1 and CysLT2 receptors.18 Expression Depsipeptide in vitro of CysLTR1 has been demonstrated in murine DCs.40 Our objective was to evaluate the expression of both receptors in immature and LPS-stimulated DCs by reverse transcription (RT-) PCR. For that, DCs were incubated without or with LPS (1 μg/ml) at 37°, after 30 min we added or not 10–8 m LTC4 and cells were cultured overnight at 37° and finally we analysed the expression of both receptors using RT-PCR. The RT-PCR amplification yielded DNA fragments of the expected size for both CysLTR1 and CysLTR2 (Fig. 4a). By analysis of bands compared with β-actin, we found similar expression for both receptors in immature and LPS-stimulated DCs (Fig. 4b), an interesting fact was that, LTC4 treatment of immature DCs up-regulated the expression of CysLTR1 mRNA. This could suggest that the effects of LTC4 are mediated through the CysLTR1. However, when we analysed DX uptake and cytokine secretion in the presence of montelukast (MK-571), an antagonist of CysLTR1, we found that DX endocytosis only decreased the mean fluorescence intensity in immature DCs by 25–30% (control: 78·2 ± 8·1; LTC4: 165·5 ± 12·4 versus MK-571: 91 ± 15·1; MK-571 + LTC4: 108 ± 21·0, mean ± SEM, n = 3, P < 0·05).